BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36617735)

  • 21. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3.
    Yin L; Chen J; Ma C; Pei S; Du M; Zhang Y; Feng Y; Yin R; Bian X; He X; Feng J
    Cell Death Dis; 2020 Jul; 11(7):562. PubMed ID: 32703944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA circSHPRH inhibits the malignant behaviors of bladder cancer by regulating the miR-942/BARX2 pathway.
    Zuo L; Zhu Y; Han J; Liu H
    Aging (Albany NY); 2022 Feb; 14(4):1891-1909. PubMed ID: 35200157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway.
    Zhang J; Wang L; Jiang J; Qiao Z
    J Cell Biochem; 2020 Dec; 121(12):4699-4710. PubMed ID: 33135285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hsa_circ_0088196 suppresses trophoblast migration and invasion by the miR-525-5p/ABL1 axis and the PI3K/AKT signaling pathway.
    Shi F; Li L
    J Biochem Mol Toxicol; 2022 Oct; 36(10):e23150. PubMed ID: 35781906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
    Wu X; Xu Q; Li T; Wei Y; Zeng R; Lin R; Xu L; Ye L; Liu Z
    Appl Biochem Biotechnol; 2023 Jul; 195(7):4116-4133. PubMed ID: 36656536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircRAPGEF5 sponges miR-582-3p and targets KIF3A to regulate bladder cancer cell proliferation, migration and invasion.
    Wang C; Yang X
    Int Immunopharmacol; 2024 Apr; 131():111613. PubMed ID: 38489970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
    Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
    Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
    Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
    J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
    Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
    Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis.
    Shi J; Liu C; Chen C; Guo K; Tang Z; Luo Y; Chen L; Su Y; Xu K
    Aging (Albany NY); 2020 Jul; 12(13):13255-13280. PubMed ID: 32645691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsa_circ_0008934 promotes the proliferation and migration of osteosarcoma cells by targeting miR-145-5p to enhance E2F3 expression.
    Li S; Zeng M; Yang L; Tan J; Yang J; Guan H; Kuang M; Li J
    Int J Biochem Cell Biol; 2020 Oct; 127():105826. PubMed ID: 32822848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal lncRNA LINC02191 Promotes Laryngeal Squamous cell Carcinoma Progression by Targeting miR-204-5p/RAB22A Axis and Regulating PI3K/Akt/mTOR Pathway.
    Kang Z; Zhang C; Huangfu H
    Biochem Genet; 2024 Jun; 62(3):2117-2133. PubMed ID: 37863866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
    Lin S; Wang L; Shi Z; Zhu A; Zhang G; Hong Z; Cheng C
    Bioengineered; 2021 Dec; 12(2):11376-11389. PubMed ID: 34852712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. circ3323 Motivates Host Gene to Promote the Aggressiveness of Bladder Cancer.
    Wu X; Cao W; Lu C; Zuo L; Liu X; Qi M
    Biochem Genet; 2022 Dec; 60(6):2327-2345. PubMed ID: 35362879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.